Mesoportal bypass, interposition graft, and mesocaval shunt: Surgical strategies to overcome superior mesenteric vein involvement in pancreatic cancer
Author:
Kinny-Köster Benedict,
van Oosten Floortje,
Habib Joseph R.,
Javed Ammar A.,
Cameron John L.,
Lafaro Kelly J.,
Burkhart Richard A.,
Burns William R.,
He JinORCID,
Fishman Elliot K.ORCID,
Wolfgang Christopher L.
Reference29 articles.
1. Complications of pancreatic surgery;Ho;HPB,2005
2. Two thousand consecutive pancreaticoduodenectomies;Cameron;J Am Coll Surg,2015
3. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017
4. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018
5. Pancreatic adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology;Tempero;J Natl Compr Canc Netw,2017
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献